Growing community of inventors

Yokohama, Japan

Masanori Kamei

Average Co-Inventor Count = 3.95

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 11

Masanori KameiYuko Matsui (2 patents)Masanori KameiKenkichi Sugiyama (2 patents)Masanori KameiMasatoshi Kato (1 patent)Masanori KameiTakashi Mato (1 patent)Masanori KameiToshio Takahashi (1 patent)Masanori KameiShuichi Hashizume (1 patent)Masanori KameiNaoko Maruo (1 patent)Masanori KameiTatsuo Watanabe (1 patent)Masanori KameiShunji Saitoh (1 patent)Masanori KameiAkitaka Shibuya (1 patent)Masanori KameiYumiko Tani (1 patent)Masanori KameiKoji Yanae (1 patent)Masanori KameiHaruhiko Tsutsumi (1 patent)Masanori KameiRyouichi Ito (1 patent)Masanori KameiMasanori Kamei (5 patents)Yuko MatsuiYuko Matsui (5 patents)Kenkichi SugiyamaKenkichi Sugiyama (4 patents)Masatoshi KatoMasatoshi Kato (6 patents)Takashi MatoTakashi Mato (4 patents)Toshio TakahashiToshio Takahashi (4 patents)Shuichi HashizumeShuichi Hashizume (4 patents)Naoko MaruoNaoko Maruo (4 patents)Tatsuo WatanabeTatsuo Watanabe (2 patents)Shunji SaitohShunji Saitoh (2 patents)Akitaka ShibuyaAkitaka Shibuya (2 patents)Yumiko TaniYumiko Tani (1 patent)Koji YanaeKoji Yanae (1 patent)Haruhiko TsutsumiHaruhiko Tsutsumi (1 patent)Ryouichi ItoRyouichi Ito (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Morinaga Co. Ltd. (4 from 40 patents)

2. Ajinomoto Co., Ltd. (1 from 1,929 patents)

3. Tosoh Corporation (1 from 895 patents)


5 patents:

1. 9393191 - Piceatannol-containing composition and method of producing piceatannol-containing composition

2. 8617620 - Piceatannol-containing composition and method of producing piceatannol-containing composition

3. 7414075 - Composition for lowering internal lipid content

4. 6488969 - Method for reducing blood ammonia concentration

5. 5741652 - Anti-human type IV collagen antibodies and use thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/10/2026
Loading…